This Dividend ETF Has Outperformed Many Actively Managed Funds Over 10 Years

First Trust Rising Dividend Achievers ETF (RDVY) cites a 16.5% average annual return over the past decade (No. 1 in U.S. dividend ETFs), outperforming the next-closest peer by 2+ percentage points and beating the Vanguard S&P 500 ETF over the same period. The index screens for companies with rising dividends, improving positive EPS trends, cash-to-debt >50, and payout ratio ≤65%, with financials ~31% and top tech names (e.g., Applied Materials, Lam Research, KLA). However, the fund is described as top-heavy (56% combined financials+tech) with a 0.8% current yield and a higher 0.47% expense ratio, limiting appeal for income-focused investors.

Analysis

RDVY is less a dividend product than a quality-growth factor sleeve with a dividend screen attached. That matters because the marginal buyers are likely chasing total return, not income, so the real beneficiaries are the highest-duration constituents inside the basket, especially semicap equipment names like AMAT and LRCX that can compound through capex cycles while still clearing the screen.

The near-term catalyst is flow, not fundamentals: a promotional piece can pull in retail and advisor assets, but the 0.8% yield means this competes more with quality ETFs than with true income funds. The second-order effect is a relative-bid for profitable, cash-rich cyclicals and financials, while lower-quality dividend names lose mindshare; if credit spreads widen or semiconductor capex rolls over, both dominant sleeves can de-rate at once.

Contrarian take: the market may be overrating the backtest and underrating concentration risk. A 47 bps fee for a rules-based basket is hard to justify if cheaper vehicles or direct stock baskets can replicate the same factor exposure. I would treat this as a 1-3 month relative-value story, not a long-duration thesis; the thesis breaks if RDVY fails to outperform VIG/SCHD on a risk-on tape or if AMAT/LRCX guide down capex expectations.

Key Decisions for Investors

• Do not chase RDVY outright after the article; wait for a 3-5% pullback or confirmed relative strength versus VIG/SCHD before adding. Falsify the setup if RDVY lags those peers by more than 2% over the next month.
• If you want the factor exposure, buy AMAT/LRCX directly rather than the ETF. The upside is less diluted, and you avoid paying 47 bps for a basket you can replicate more efficiently.
• Pair trade: long RDVY / short SCHD for 3-6 months only if rates stabilize and quality-growth stays in favor. Target a 3-5% spread, stop if yield/defensive leadership reasserts or semicap earnings weaken.
• Watch for a reversal trigger in AMAT and LRCX guidance; any capex slowdown would pressure the ETF’s highest-conviction sleeve and invalidate the quality-growth read-through.